Health Highlights: Jan. 17, 201101/17/11
Here are some of the latest health and medical news
developments, compiled by the editors of HealthDay:
Apple CEO Steve Jobs Takes Medical Leave
Apple Inc. CEO Steve Jobs is taking his second medical leave of
absence in two years in order to focus on his health.
He announced his intentions in a note Monday to company
employees, but no further information was provided about his
current condition, the
Associated Press reported.
In 2004, Jobs was treated for a rare form of pancreatic cancer
and in 2009 he had a liver transplant.
Jobs said he will continue as CEO during his medical leave and
will be involved in major decisions, but the company's chief
operating officer will be responsible for day-to-day operations,
Opposition to Health Care Law Decreases: Poll
The level of opposition to the U.S. health care law has
decreased, according to a phone survey of 1,001 adults conducted
Associated Press-GfK poll found that 41 percent of
respondents oppose the law, while 40 percent support it. Following
November's congressional elections, opposition was 47 percent and
support was 38 percent.
Opposition remains strongest among Republicans, with 71 percent
against it, while 35 percent of independents and 19 percent of
Democrats are oppose the law.
Overall, strong opposition to the law is 30 percent, which is
close to the lowest level recorded in
AP-GfK polls going back to September 2009.
Only about one in four respondents want the law repealed, 43
percent want it changed so that it does more to rework the health
care system, and fewer than one in five want it left as it is, the
Nearly six in 10 respondents are against the law's requirement
that people must have health insurance or face penalties.
A Republican-led vote on repealing the health care law is
expected to take place this week in the House.
Large Recall of Tylenol, Sudafed
Nearly 47 million packages of Tylenol, Sudafed and other
nonprescription drugs have been recalled due to insufficient
cleaning procedures, says Johnson & Johnson.
The recall affects wholesalers in the United States, the
Caribbean and Brazil, but consumers don't have to take any action,
according to the company, the
Associated Press reported.
The new recall is just the latest in a series of large recalls
of products made at Johnson & Johnson's plant in Fort
Washington, Pa., which was closed in April following a Food and
Drug Administration investigation that revealed a number of
problems. These included some equipment coated in thick layers of
dust and duct tape holding together other pieces of equipment.
On Friday, the company also announced a recall of Rolaids
tablets because they do not have certain labeling information, the
Copyright © 2011
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.